Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
| Published in: | JEADV Clinical Practice |
|---|---|
| Format: | Online Article RSS Article |
| Published: |
2026
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|
| _version_ | 1867301678780252160 |
|---|---|
| collection | WordPress RSS FRELIP Feed Integration |
| container_title | JEADV Clinical Practice |
| description | |
| discipline_display | Dermatology and Venereology |
| discipline_facet | Dermatology and Venereology |
| format | Online Article RSS Article |
| genre | Journal Article |
| id | rss_article:76748 |
| institution | FRELIP |
| journal_source_facet | JEADV Clinical Practice |
| publishDate | 2026 |
| publishDateSort | 2026 |
| record_format | rss_article |
| spellingShingle | Efficacy of Lebrikizumab in Patients With Severe Atopic Dermatitis Who Would be Eligible for Treatment Based on the South Korean Reimbursement Criteria Dermatology and Venereology General Dermatology and Venereology |
| sub_discipline_display | General |
| sub_discipline_facet | General |
| subject_display | Dermatology and Venereology General Dermatology and Venereology Dermatology and Venereology General Dermatology and Venereology |
| subject_facet | Dermatology and Venereology General Dermatology and Venereology |
| title | Efficacy of Lebrikizumab in Patients With Severe Atopic Dermatitis Who Would be Eligible for Treatment Based on the South Korean Reimbursement Criteria |
| title_auth | Efficacy of Lebrikizumab in Patients With Severe Atopic Dermatitis Who Would be Eligible for Treatment Based on the South Korean Reimbursement Criteria |
| title_full | Efficacy of Lebrikizumab in Patients With Severe Atopic Dermatitis Who Would be Eligible for Treatment Based on the South Korean Reimbursement Criteria |
| title_fullStr | Efficacy of Lebrikizumab in Patients With Severe Atopic Dermatitis Who Would be Eligible for Treatment Based on the South Korean Reimbursement Criteria |
| title_full_unstemmed | Efficacy of Lebrikizumab in Patients With Severe Atopic Dermatitis Who Would be Eligible for Treatment Based on the South Korean Reimbursement Criteria |
| title_short | Efficacy of Lebrikizumab in Patients With Severe Atopic Dermatitis Who Would be Eligible for Treatment Based on the South Korean Reimbursement Criteria |
| title_sort | efficacy of lebrikizumab in patients with severe atopic dermatitis who would be eligible for treatment based on the south korean reimbursement criteria |
| topic | Dermatology and Venereology General Dermatology and Venereology |
| url | https://onlinelibrary.wiley.com/doi/10.1002/jvc2.70271?af=R |